Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 439

1.

NCCN Guidelines Insights: Colorectal Cancer Screening, Version 1.2018.

Provenzale D, Gupta S, Ahnen DJ, Markowitz AJ, Chung DC, Mayer RJ, Regenbogen SE, Blanco AM, Bray T, Cooper G, Early DS, Ford JM, Giardiello FM, Grady W, Hall MJ, Halverson AL, Hamilton SR, Hampel H, Klapman JB, Larson DW, Lazenby AJ, Llor X, Lynch PM, Mikkelson J, Ness RM, Slavin TP, Sugandha S, Weiss JM, Dwyer MA, Ogba N.

J Natl Compr Canc Netw. 2018 Aug;16(8):939-949. doi: 10.6004/jnccn.2018.0067.

PMID:
30099370
2.

The Translaminar Pressure Gradient: Papilledema After Trabeculectomy Treated With Optic Nerve Sheath Fenestration.

Radke PM, Rubinstein TJ, Hamilton SR, Jamil AL, Sires BS.

J Glaucoma. 2018 Oct;27(10):e154-e157. doi: 10.1097/IJG.0000000000001021.

PMID:
29979338
3.

Characterizing the Killer Colorectal Carcinomas.

Hamilton SR.

Cancer Cell. 2018 Jan 8;33(1):7-9. doi: 10.1016/j.ccell.2017.12.010.

4.

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017.

Gupta S, Provenzale D, Regenbogen SE, Hampel H, Slavin TP, Hall MJ, Llor X, Chung DC, Ahnen DJ, Bray T, Cooper G, Early DS, Ford JM, Giardiello FM, Grady W, Halverson AL, Hamilton SR, Klapman JB, Larson DW, Lazenby AJ, Lynch PM, Markowitz AJ, Mayer RJ, Ness RM, Samadder NJ, Shike M, Sugandha S, Weiss JM, Dwyer MA, Ogba N.

J Natl Compr Canc Netw. 2017 Dec;15(12):1465-1475. doi: 10.6004/jnccn.2017.0176.

PMID:
29223984
5.

Status of Testing for High-Level Microsatellite Instability/Deficient Mismatch Repair in Colorectal Carcinoma.

Hamilton SR.

JAMA Oncol. 2018 Feb 8;4(2):e173574. doi: 10.1001/jamaoncol.2017.3574. Epub 2018 Feb 8. No abstract available.

PMID:
29121141
6.

Glycogen Synthase Kinase-3 Modulates Cbl-b and Constrains T Cell Activation.

Tran CW, Saibil SD, Le Bihan T, Hamilton SR, Lang KS, You H, Lin AE, Garza KM, Elford AR, Tai K, Parsons ME, Wigmore K, Vainberg MG, Penninger JM, Woodgett JR, Mak TW, Ohashi PS.

J Immunol. 2017 Dec 15;199(12):4056-4065. doi: 10.4049/jimmunol.1600396. Epub 2017 Nov 6.

7.

Apoptosis and expression of apoptosis-related genes in mouse intestinal tissue after whole-body proton exposure.

Purgason A, Zhang Y, Hamilton SR, Gridley DS, Sodipe A, Jejelowo O, Ramesh GT, Moreno-Villanueva M, Wu H.

Mol Cell Biochem. 2018 May;442(1-2):155-168. doi: 10.1007/s11010-017-3200-0. Epub 2017 Nov 2.

PMID:
29098506
8.

A Blueprint to Advance Colorectal Cancer Immunotherapies.

Le DT, Hubbard-Lucey VM, Morse MA, Heery CR, Dwyer A, Marsilje TH, Brodsky AN, Chan E, Deming DA, Diaz LA Jr, Fridman WH, Goldberg RM, Hamilton SR, Housseau F, Jaffee EM, Kang SP, Krishnamurthi SS, Lieu CH, Messersmith W, Sears CL, Segal NH, Yang A, Moss RA, Cha E, O'Donnell-Tormey J, Roach N, Davis AQ, McAbee K, Worrall S, Benson AB.

Cancer Immunol Res. 2017 Nov;5(11):942-949. doi: 10.1158/2326-6066.CIR-17-0375. Epub 2017 Oct 16.

9.

Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial.

Khoury JD, Wang WL, Prieto VG, Medeiros LJ, Kalhor N, Hameed M, Broaddus R, Hamilton SR.

Clin Cancer Res. 2018 Feb 1;24(3):521-531. doi: 10.1158/1078-0432.CCR-17-1597. Epub 2017 Aug 24. Review.

10.

Perioperative Vision Loss in Cervical Spinal Surgery.

Gabel BC, Lam A, Chapman JR, Oskouian RJ Jr, Nassr A, Currier BL, Sebastian AS, Arnold PM, Hamilton SR, Fehlings MG, Mroz TE, Riew KD.

Global Spine J. 2017 Apr;7(1 Suppl):91S-95S. doi: 10.1177/2192568216688196. Epub 2017 Apr 1.

11.

FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma.

Korphaisarn K, Morris VK, Overman MJ, Fogelman DR, Kee BK, Raghav KPS, Manuel S, Shureiqi I, Wolff RA, Eng C, Menter D, Hamilton SR, Kopetz S, Dasari A.

Oncotarget. 2017 Jun 13;8(24):39268-39279. doi: 10.18632/oncotarget.16848.

12.

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline Summary From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.

Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C, Lindor NM, Minsky BD, Monzon FA, Sargent DJ, Singh VM, Willis J, Clark J, Colasacco C, Rumble RB, Temple-Smolkin R, Ventura CB, Nowak JA.

J Oncol Pract. 2017 May;13(5):333-337. doi: 10.1200/JOP.2017.022152. Epub 2017 Mar 28. No abstract available.

PMID:
28350513
13.

Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial.

Lih CJ, Harrington RD, Sims DJ, Harper KN, Bouk CH, Datta V, Yau J, Singh RR, Routbort MJ, Luthra R, Patel KP, Mantha GS, Krishnamurthy S, Ronski K, Walther Z, Finberg KE, Canosa S, Robinson H, Raymond A, Le LP, McShane LM, Polley EC, Conley BA, Doroshow JH, Iafrate AJ, Sklar JL, Hamilton SR, Williams PM.

J Mol Diagn. 2017 Mar;19(2):313-327. doi: 10.1016/j.jmoldx.2016.10.007. Epub 2017 Feb 7.

14.

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.

Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C, Lindor NM, Minsky BD, Monzon FA, Sargent DJ, Singh VM, Willis J, Clark J, Colasacco C, Rumble RB, Temple-Smolkin R, Ventura CB, Nowak JA.

J Mol Diagn. 2017 Mar;19(2):187-225. doi: 10.1016/j.jmoldx.2016.11.001. Epub 2017 Feb 6. Review.

15.

Molecular Biomarkers for the Evaluation of Colorectal Cancer.

Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C, Lindor NM, Minsky BD, Monzon FA, Sargent DJ, Singh VM, Willis J, Clark J, Colasacco C, Rumble RB, Temple-Smolkin R, Ventura CB, Nowak JA.

Am J Clin Pathol. 2017 Feb 3. doi: 10.1093/ajcp/aqw209. [Epub ahead of print] No abstract available.

PMID:
28165529
16.

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology.

Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C, Lindor NM, Minsky BD, Monzon FA, Sargent DJ, Singh VM, Willis J, Clark J, Colasacco C, Rumble RB, Temple-Smolkin R, Ventura CB, Nowak JA.

J Clin Oncol. 2017 May 1;35(13):1453-1486. doi: 10.1200/JCO.2016.71.9807. Epub 2017 Feb 6. Review.

PMID:
28165299
17.

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.

Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C, Lindor NM, Minsky BD, Monzon FA, Sargent DJ, Singh VM, Willis J, Clark J, Colasacco C, Bryan Rumble R, Temple-Smolkin R, B Ventura C, Nowak JA.

Arch Pathol Lab Med. 2017 May;141(5):625-657. doi: 10.5858/arpa.2016-0554-CP. Epub 2017 Feb 6.

PMID:
28165284
18.

MIIP haploinsufficiency induces chromosomal instability and promotes tumour progression in colorectal cancer.

Sun Y, Ji P, Chen T, Zhou X, Yang D, Guo Y, Liu Y, Hu L, Xia D, Liu Y, Multani AS, Shmulevich I, Kucherlapati R, Kopetz S, Sood AK, Hamilton SR, Sun B, Zhang W.

J Pathol. 2017 Jan;241(1):67-79. doi: 10.1002/path.4823. Epub 2016 Nov 24.

19.

MicroRNA Signatures of Colonic Polyps on Screening and Histology.

Tsikitis VL, Potter A, Mori M, Buckmeier JA, Preece CR, Harrington CA, Bartley AN, Bhattacharyya AK, Hamilton SR, Lance MP, Thompson PA.

Cancer Prev Res (Phila). 2016 Dec;9(12):942-949. Epub 2016 Sep 22.

20.

Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes.

Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F, Bhattacharyya A, Hsu CH, Chow HH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Hamilton SR, Jacobs ET, Martinez ME, Alberts DS, Lance P.

J Natl Cancer Inst. 2016 Aug 16;108(12). pii: djw152. doi: 10.1093/jnci/djw152. Print 2016 Dec.

21.

Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial.

Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F, Bhattacharyya A, Hsu CH, Chow SH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Hamilton SR, Jacobs ET, Martinez EM, Alberts DS, Lance P.

J Natl Cancer Inst. 2016 Aug 16;108(12). pii: djw151. doi: 10.1093/jnci/djw151. Print 2016 Dec.

22.

Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

Provenzale D, Gupta S, Ahnen DJ, Bray T, Cannon JA, Cooper G, David DS, Early DS, Erwin D, Ford JM, Giardiello FM, Grady W, Halverson AL, Hamilton SR, Hampel H, Ismail MK, Klapman JB, Larson DW, Lazenby AJ, Lynch PM, Mayer RJ, Ness RM, Regenbogen SE, Samadder NJ, Shike M, Steinbach G, Weinberg D, Dwyer M, Darlow S.

J Natl Compr Canc Netw. 2016 Aug;14(8):1010-30.

PMID:
27496117
23.

Clinical and Molecular Characteristics of Post-Colonoscopy Colorectal Cancer: A Population-based Study.

Stoffel EM, Erichsen R, Frøslev T, Pedersen L, Vyberg M, Koeppe E, Crockett SD, Hamilton SR, Sørensen HT, Baron JA.

Gastroenterology. 2016 Nov;151(5):870-878.e3. doi: 10.1053/j.gastro.2016.07.010. Epub 2016 Jul 19.

24.

Molecular Triage Trials in Colorectal Cancer.

O'Hara MH, Hamilton SR, O'Dwyer PJ.

Cancer J. 2016 May-Jun;22(3):218-22. doi: 10.1097/PPO.0000000000000199. Review.

PMID:
27341602
25.

Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer.

Lee MS, McGuffey EJ, Morris JS, Manyam G, Baladandayuthapani V, Wei W, Morris VK, Overman MJ, Maru DM, Jiang ZQ, Hamilton SR, Kopetz S.

Br J Cancer. 2016 Jun 14;114(12):1352-61. doi: 10.1038/bjc.2016.87. Epub 2016 Jun 7.

26.

Examining plasma microRNA markers for colorectal cancer at different stages.

Sun Y, Liu Y, Cogdell D, Calin GA, Sun B, Kopetz S, Hamilton SR, Zhang W.

Oncotarget. 2016 Mar 8;7(10):11434-49. doi: 10.18632/oncotarget.7196.

27.

Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer.

Leichman L, Groshen S, O'Neil BH, Messersmith W, Berlin J, Chan E, Leichman CG, Cohen SJ, Cohen D, Lenz HJ, Gold P, Boman B, Fielding A, Locker G, Cason RC, Hamilton SR, Hochster HS.

Oncologist. 2016 Feb;21(2):172-7. doi: 10.1634/theoncologist.2015-0319. Epub 2016 Jan 19.

28.

Cohort Profile: The MD Anderson Cancer Patients and Survivors Cohort (MDA-CPSC).

Wu X, Hildebrandt MA, Ye Y, Chow WH, Gu J, Cunningham S, Zhao H, Hawk ET, Wagar E, Rodriguez A, Hamilton SR.

Int J Epidemiol. 2016 Jun;45(3):713-713f. doi: 10.1093/ije/dyv317. Epub 2015 Dec 20. No abstract available.

29.

Increased Risk of Colorectal Cancer Development Among Patients With Serrated Polyps.

Erichsen R, Baron JA, Hamilton-Dutoit SJ, Snover DC, Torlakovic EE, Pedersen L, Frøslev T, Vyberg M, Hamilton SR, Sørensen HT.

Gastroenterology. 2016 Apr;150(4):895-902.e5. doi: 10.1053/j.gastro.2015.11.046. Epub 2015 Dec 8.

PMID:
26677986
30.

Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing.

Estrella JS, Tetzlaff MT, Bassett RL Jr, Patel KP, Williams MD, Curry JL, Rashid A, Hamilton SR, Broaddus RR.

Mol Cancer Ther. 2015 Dec;14(12):2887-95. doi: 10.1158/1535-7163.MCT-15-0615. Epub 2015 Oct 5.

31.

Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015.

Allegra CJ, Rumble RB, Hamilton SR, Mangu PB, Roach N, Hantel A, Schilsky RL.

J Clin Oncol. 2016 Jan 10;34(2):179-85. doi: 10.1200/JCO.2015.63.9674. Epub 2015 Oct 5. Review.

PMID:
26438111
32.

Colorectal Cancer Screening, Version 1.2015.

Provenzale D, Jasperson K, Ahnen DJ, Aslanian H, Bray T, Cannon JA, David DS, Early DS, Erwin D, Ford JM, Giardiello FM, Gupta S, Halverson AL, Hamilton SR, Hampel H, Ismail MK, Klapman JB, Larson DW, Lazenby AJ, Lynch PM, Mayer RJ, Ness RM, Rao MS, Regenbogen SE, Shike M, Steinbach G, Weinberg D, Dwyer MA, Freedman-Cass DA, Darlow S; National comprehensive cancer netwok.

J Natl Compr Canc Netw. 2015 Aug;13(8):959-68; quiz 968.

PMID:
26285241
33.

Progress in Yeast Glycosylation Engineering.

Hamilton SR, Zha D.

Methods Mol Biol. 2015;1321:73-90. doi: 10.1007/978-1-4939-2760-9_6. Review.

PMID:
26082216
34.

Improvement in Visual Fields After Treatment of Intracranial Meningioma With Bevacizumab.

Ly KI, Hamilton SR, Rostomily RC, Rockhill JK, Mrugala MM.

J Neuroophthalmol. 2015 Dec;35(4):382-6. doi: 10.1097/WNO.0000000000000253.

PMID:
26049681
35.

Regulation of AURKC expression by CpG island methylation in human cancer cells.

Fujii S, Srivastava V, Hegde A, Kondo Y, Shen L, Hoshino K, Gonzalez Y, Wang J, Sasai K, Ma X, Katayama H, Estecio MR, Hamilton SR, Wistuba I, Issa JP, Sen S.

Tumour Biol. 2015 Sep;36(10):8147-58. doi: 10.1007/s13277-015-3553-5. Epub 2015 May 20.

PMID:
25990457
36.

The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.

Ling H, Pickard K, Ivan C, Isella C, Ikuo M, Mitter R, Spizzo R, Bullock M, Braicu C, Pileczki V, Vincent K, Pichler M, Stiegelbauer V, Hoefler G, Almeida MI, Hsiao A, Zhang X, Primrose J, Packham G, Liu K, Bojja K, Gafà R, Xiao L, Rossi S, Song JH, Vannini I, Fanini F, Kopetz S, Zweidler-McKay P, Wang X, Ionescu C, Irimie A, Fabbri M, Lanza G, Hamilton SR, Berindan-Neagoe I, Medico E, Mirnezami A, Calin GA, Nicoloso MS.

Gut. 2016 Jun;65(6):977-989. doi: 10.1136/gutjnl-2015-309372. Epub 2015 Mar 24.

37.

Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.

Stoffel EM, Mangu PB, Gruber SB, Hamilton SR, Kalady MF, Lau MW, Lu KH, Roach N, Limburg PJ; American Society of Clinical Oncology; European Society of Clinical Oncology.

J Clin Oncol. 2015 Jan 10;33(2):209-17. doi: 10.1200/JCO.2014.58.1322. Epub 2014 Dec 1.

38.

Pragmatic issues in biomarker evaluation for targeted therapies in cancer.

de Gramont A, Watson S, Ellis LM, Rodón J, Tabernero J, de Gramont A, Hamilton SR.

Nat Rev Clin Oncol. 2015 Apr;12(4):197-212. doi: 10.1038/nrclinonc.2014.202. Epub 2014 Nov 25. Review.

PMID:
25421275
39.

A practical approach for O-linked mannose removal: the use of recombinant lysosomal mannosidase.

Hopkins D, Gomathinayagam S, Hamilton SR.

Appl Microbiol Biotechnol. 2015 May;99(9):3913-27. doi: 10.1007/s00253-014-6189-2. Epub 2014 Nov 11.

PMID:
25381909
40.

Select biomarkers for tumors of the gastrointestinal tract: present and future.

Bartley AN, Hamilton SR.

Arch Pathol Lab Med. 2015 Apr;139(4):457-68. doi: 10.5858/arpa.2014-0189-RA. Epub 2014 Oct 21. Review.

PMID:
25333834
41.

Template for Reporting Results of HER2 (ERBB2) Biomarker Testing of Specimens From Patients With Adenocarcinoma of the Stomach or Esophagogastric Junction.

Bartley AN, Christ J, Fitzgibbons PL, Hamilton SR, Kakar S, Shah MA, Tang LH, Troxell ML; Members of the Cancer Biomarker Reporting Committee, College of American Pathologists.

Arch Pathol Lab Med. 2015 May;139(5):618-20. doi: 10.5858/arpa.2014-0395-CP. Epub 2014 Oct 2. No abstract available.

PMID:
25275813
42.

Differential expression of microRNA-320a, -145, and -192 along the continuum of normal mucosa to high-grade dysplastic adenomas of the colorectum.

Tsikitis VL, White I, Mori M, Potter A, Bhattcharyya A, Hamilton SR, Buckmeier J, Lance P, Thompson P.

Am J Surg. 2014 May;207(5):717-22; discussion 722. doi: 10.1016/j.amjsurg.2013.12.023. Epub 2014 Mar 12.

43.

MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit.

Jardim DL, de Melo Gagliato D, Falchook GS, Janku F, Zinner R, Wheler JJ, Subbiah V, Piha-Paul SA, Fu S, Murphy MB, Ajani J, Tang C, Hess K, Hamilton SR, Roy-Chowdhuri S, Kurzrock R, Meric-Bernstam F, Hong DS.

Oncotarget. 2014 Apr 15;5(7):1837-45.

44.

Evidence of clinical utility: an unmet need in molecular diagnostics for patients with cancer.

Parkinson DR, McCormack RT, Keating SM, Gutman SI, Hamilton SR, Mansfield EA, Piper MA, Deverka P, Frueh FW, Jessup JM, McShane LM, Tunis SR, Sigman CC, Kelloff GJ.

Clin Cancer Res. 2014 Mar 15;20(6):1428-44. doi: 10.1158/1078-0432.CCR-13-2961.

45.

IRF4 and BATF are critical for CD8⁺ T-cell function following infection with LCMV.

Grusdat M, McIlwain DR, Xu HC, Pozdeev VI, Knievel J, Crome SQ, Robert-Tissot C, Dress RJ, Pandyra AA, Speiser DE, Lang E, Maney SK, Elford AR, Hamilton SR, Scheu S, Pfeffer K, Bode J, Mittrücker HW, Lohoff M, Huber M, Häussinger D, Ohashi PS, Mak TW, Lang KS, Lang PA.

Cell Death Differ. 2014 Jul;21(7):1050-60. doi: 10.1038/cdd.2014.19. Epub 2014 Feb 14.

46.

In vitro enzymatic treatment to remove O-linked mannose from intact glycoproteins.

Gomathinayagam S, Hamilton SR.

Appl Microbiol Biotechnol. 2014 Mar;98(6):2545-54. doi: 10.1007/s00253-013-5478-5. Epub 2014 Feb 14.

PMID:
24526361
47.

Elimination of diaminopeptidase activity in Pichia pastoris for therapeutic protein production.

Hopkins D, Gomathinayagam S, Lynaugh H, Stadheim TA, Hamilton SR.

Appl Microbiol Biotechnol. 2014 Mar;98(6):2573-83. doi: 10.1007/s00253-013-5468-7. Epub 2014 Feb 14.

PMID:
24526360
48.

Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells.

Brenner D, Brüstle A, Lin GH, Lang PA, Duncan GS, Knobbe-Thomsen CB, St Paul M, Reardon C, Tusche MW, Snow B, Hamilton SR, Pfefferle A, Gilani SO, Ohashi PS, Lang KS, Mak TW.

Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1060-5. doi: 10.1073/pnas.1323166111. Epub 2014 Jan 7.

49.

Colorectal cancer screening.

Burt RW, Cannon JA, David DS, Early DS, Ford JM, Giardiello FM, Halverson AL, Hamilton SR, Hampel H, Ismail MK, Jasperson K, Klapman JB, Lazenby AJ, Lynch PM, Mayer RJ, Ness RM, Provenzale D, Rao MS, Shike M, Steinbach G, Terdiman JP, Weinberg D, Dwyer M, Freedman-Cass D; National comprehensive cancer network.

J Natl Compr Canc Netw. 2013 Dec 1;11(12):1538-75.

PMID:
24335688
50.

Animal toxicity of hairpin pyrrole-imidazole polyamides varies with the turn unit.

Yang F, Nickols NG, Li BC, Szablowski JO, Hamilton SR, Meier JL, Wang CM, Dervan PB.

J Med Chem. 2013 Sep 26;56(18):7449-57. doi: 10.1021/jm401100s. Epub 2013 Sep 9.

Supplemental Content

Loading ...
Support Center